Editorial
“Management is doing things right; leadership is doing the right things” said Warren Bennis. As we draw the curtains on the final issue of 2023, it’s time to look back and reflect, with a sense of accomplishment and gratitude, on this year’s important landmarks. At each step of 2023, we believed in doing the right things.
Chris De Jonghe
Valorization Director
Jan Paul Medema
Head of Oncode Institute & Scientific Director
Our institute has seen important changes in management this year. First, we said goodbye to our previous Head of Oncode Institute & Scientific Director, Geert Kops. Starting October, I had the pleasure to step in his footsteps and take over this role in the institute. Further on, we welcomed Melvin Samson as our new Chair of the Supervisory Board.
“In my new role, I am excited about the future of Oncode, refining our plans and gearing up for 2024.”
In my new role, I am excited about the future of Oncode Institute - refining our plans and gearing up for 2024. In this issue, you can read the blog section to find out more about who I am and what drives me, and about my vision for Oncode Institute.
Altogether, I can easily see that the past twelve months have been nothing short of transformative for our institute, marked by change and growth. One important highlight of the year has been the recent recruitment of 10 new talented Oncode Investigators, who not only expand and strengthen our community, but also add fresh expertise and perspectives. Their joining makes us stronger in our quest to find solutions for cancer and bring them to the clinic.
Read the Portrait section to get to know Oncode Investigator Wilbert Zwart better. And then dive deep into the science and the workings of Monika Wolkers’ lab at Sanquin through our Lab Visit. Also, make sure not to miss the Eureka section to catch up with our latest news and updates.
And last, in line with the launch of Oncode Accelerator this year, the Dialogue in this issue is a special one, showcasing our synergy. We interviewed Jarno Drost, who is an Oncode Investigator and also the platform lead for organoids within Oncode Accelerator, together with Marjon Pasmooij, who is the head of the science department at the Dutch Medicines Evaluation Board, chair of the Regulatory Science Network Netherlands, and also workstream lead regulatory innovation within Oncode Accelerator.
Enjoy reading!
